Publication | Open Access

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

VaccinationVaccinologyOncologyVaccine DevelopmentFinal ReportImmunologyVaccine TrialBooster InoculationsPrecision VaccinologyDisease RecurrenceVaccine EfficacyBreast CancerImmunotherapyMedicine